The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

19967,478 citationsJournal Articlebronze Open Access

Authors

Frank M. Sacks · Brigham and Women's Hospital

Marc A. Pfeffer · Harvard University

Lemuel A. Moyé · The University of Texas Health Science Center at Houston

Jean L. Rouleau · Université de Sherbrooke

John D. Rutherford · The University of Texas Southwestern Medical Center

Thomas Cole · Washington University in St. Louis

Lisa Brown

Abstract

These results demonstrate that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels.

Topics & Keywords

Lipoproteins and Cardiovascular Health Cardiac Valve Diseases and Treatments Acute Myocardial Infarction Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 335, Issue 14, pp. 1001-1009

DOI: 10.1056/nejm199610033351401

Field-Weighted Citation Impact: 368.87